SHAREHOLDERS’ EQUITY - Warrants Narrative (Details) $ / shares in Units, $ / shares in Units, $ in Thousands, $ in Thousands					12 Months Ended
	Jun. 04, 2021 CAD ($)	Jun. 18, 2020 USD ($) $ / shares shares	Jun. 18, 2020 CAD ($) shares	Jun. 11, 2020	Dec. 31, 2021 USD ($) $ / shares shares	Dec. 31, 2020 USD ($) shares	Mar. 02, 2021	Jun. 18, 2020 $ / shares	Dec. 03, 2019 shares
Class of Warrant or Right [Line Items]
Maximum value of shares offered | $	$ 60,000
Share offering, shares/units issued (in shares)		10,000,000	10,000,000		4,740,300
Share offering, price per share (in cad or usd per share) | (per share)		$ 4.97			$ 1.85			$ 6.75
Share offering, gross proceeds		$ 57,165,000	$ 77,625,000		$ 8,714
Share issuance costs | $					596	$ 3,368
Share offering, net proceeds | $					$ 8,118
Number of common shares in each unit (in shares)		1
Number of warrants in each unit (in shares)		0.5							0.5
Warrants exercise price (in cad per share) | $ / shares								$ 8.50
Warrants expiration period		2 years					60 days
Warrants outstanding (in shares)		5,750,000			6,983,140	10,142,872
Warrant liabilities | $		$ 9,206			$ 0	$ 4,304
Warrants initial fair market value (in usd per share) | $ / shares		$ 1.601
Warrants weighted average remaining contractual life					6 months 14 days
Over-allotment option
Class of Warrant or Right [Line Items]
Share offering, shares/units issued (in shares)		1,500,000	1,500,000
Abacus Health
Class of Warrant or Right [Line Items]
Share issuance ratio				0.85